Veloxis Falls as Danske Sees Astellas Threat: Copenhagen Mover

Veloxis Pharmaceuticals A/S fell the most in 11 days in Copenhagen trading after Danske Markets said the Danish maker of treatments for organ transplant patents faces pressure from a rival product by Astellas Pharma Inc.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.